These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


353 related items for PubMed ID: 11832106

  • 1. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
    Zhang Y, Ye L, Ding Q, Fang Z, Yao M, Shi D.
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
    [Abstract] [Full Text] [Related]

  • 2. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide.
    Monti S, Sciarra F, Adamo MV, Toscano V, Trotta MC, Martini C, Lanzara S, Silverio FD.
    J Androl; 1997 Jul; 18(5):488-94. PubMed ID: 9349746
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
    Mendoza P, Sánchez C, Contreras HR, Vergara J, Acevedo C, Cabezas J, Huidobro C, Noé G, Castellón EA.
    Int J Androl; 2009 Dec; 32(6):607-15. PubMed ID: 18637152
    [Abstract] [Full Text] [Related]

  • 4. Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
    van der Sluis TM, Vis AN, van Moorselaar RJ, Bui HN, Blankenstein MA, Meuleman EJ, Heijboer AC.
    BJU Int; 2012 Jan; 109(2):176-82. PubMed ID: 21992222
    [Abstract] [Full Text] [Related]

  • 5. The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia.
    Wurzel R, Ray P, Major-Walker K, Shannon J, Rittmaster R.
    Prostate Cancer Prostatic Dis; 2007 Jan; 10(2):149-54. PubMed ID: 17189955
    [Abstract] [Full Text] [Related]

  • 6. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M, Bartsch W, Thomsen M, Voigt KD.
    J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
    [Abstract] [Full Text] [Related]

  • 7. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer.
    Rittmaster R, Hahn RG, Ray P, Shannon JB, Wurzel R.
    Urology; 2008 Oct; 72(4):808-12. PubMed ID: 18718641
    [Abstract] [Full Text] [Related]

  • 8. Conversion of 3H-testosterone to dihydrotestosterone in human hypertrophic prostatic tissue.
    Baranowska B, Zgliczyński S.
    Nuklearmedizin; 1979 Oct; 18(6):297-9. PubMed ID: 94161
    [Abstract] [Full Text] [Related]

  • 9. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK, Ross M, Tate R, Chisholm GD.
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [Abstract] [Full Text] [Related]

  • 10. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate.
    Krieg M, Nass R, Tunn S.
    J Clin Endocrinol Metab; 1993 Aug; 77(2):375-81. PubMed ID: 7688377
    [Abstract] [Full Text] [Related]

  • 11. Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer.
    Heracek J, Hampl R, Hill M, Starka L, Sachova J, Kuncova J, Eis V, Urban M, Mandys V.
    Steroids; 2007 Apr; 72(4):375-80. PubMed ID: 17368496
    [Abstract] [Full Text] [Related]

  • 12. Clinical study on estramustine binding protein (EMBP) in human prostate.
    Shiina H, Igawa M, Ishibe T.
    Prostate; 1996 Sep; 29(3):169-76. PubMed ID: 8827085
    [Abstract] [Full Text] [Related]

  • 13. Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer.
    van der Sluis TM, Meuleman EJ, van Moorselaar RJ, Bui HN, Blankenstein MA, Heijboer AC, Vis AN.
    BJU Int; 2012 Jan; 109(2):183-8. PubMed ID: 21992404
    [Abstract] [Full Text] [Related]

  • 14. Androgen and prostatic stroma.
    Niu YJ, Ma TX, Zhang J, Xu Y, Han RF, Sun G.
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [Abstract] [Full Text] [Related]

  • 15. Alteration in the metabolism of dihydrotestosterone in elderly men with prostate hyperplasia.
    Morimoto I, Edmiston A, Horton R.
    J Clin Invest; 1980 Sep; 66(3):612-5. PubMed ID: 6156957
    [Abstract] [Full Text] [Related]

  • 16. Androgen concentrations and their receptors in the periurethral region are higher than those of the subcapsular zone in benign prostatic hyperplasia (BPH).
    Monti S, Di Silverio F, Toscano V, Martini C, Lanzara S, Varasano PA, Sciarra F.
    J Androl; 1998 Sep; 19(4):428-33. PubMed ID: 9733145
    [Abstract] [Full Text] [Related]

  • 17. [Expression and its significance of b-FGF in human benign prostatic hyperplasia and prostatic carcinoma tissues].
    Wang FL, Wang H, Qin WJ, Wu GJ, Zhang G, Li KN.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):203-5. PubMed ID: 15191726
    [Abstract] [Full Text] [Related]

  • 18. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
    Zhou WQ, Sun YH, Yin HL, Zhang ZY, Ge JP, Cheng W, Ma HQ, Wei W, Zhou SG, Ma HH, Gao JP.
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
    [Abstract] [Full Text] [Related]

  • 19. [Influence of dihydrotestosterone deficit on treatment of prostatic diseases regarding to contemporary methods of prostatic hypertrophy treatments].
    Laszczyńska M, Chorzepa-Nowicka K, Wylot M, Piasecka M, Gaczarzewicz D.
    Pol Merkur Lekarski; 2008 Dec; 25(150):528-30. PubMed ID: 19205388
    [Abstract] [Full Text] [Related]

  • 20. Androgens and estrogens in the plasma and prostatic tissue of normal dogs and dogs with benign prostatic hypertrophy.
    Lloyd JW, Thomas JA, Mawhinney MG.
    Invest Urol; 1975 Nov; 13(3):220-22. PubMed ID: 53217
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.